Skip to main content

EFECTOS SOBRE LA EXCITABILIDAD CELULAR DEL RECEPTOR NICOTINICO ALFA9: IMPLICACION EN EL ESTRES Y EL DOLOR NEUROPATICO

BFU2011-26253

•
Funding agency name Ministerio de Ciencia e Innovación
Funding agency acronym MICINN
Program Programa Nacional de Proyectos de Investigación Fundamental
Subprogram Subprograma de Proyectos de Investigación Fundamental no Orientada
Call Proyectos I+D
Call year 2011
State Plan 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Management unit Subdirección General de Proyectos de Investigación
Beneficiary centre UNIVERSIDAD COMPLUTENSE DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Docta Complutense
Publication Artículo científico (JournalArticle)

Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy

  • Jimenez-Pacheco, Alba
  • Díaz Hernández, Miguel
  • Arribas Blázquez, Marina
  • Sanz-Rodriguez, Amaya
  • Olivos Ore, Luis Alcides
  • Rodríguez Artalejo, Antonio
  • Alves, Mariana
  • Letavic, Michael
  • Miras Portugal, María Teresa
  • Conroy, Ronan M.
  • Delanty, Norman
  • Farrell, Michael A.
  • O'Brien, Donncha F.
  • Bhattacharya, Anindya
  • Engel, Tobias
  • Henshall, David C.
Neuroinflammation is thought to contribute to the pathogenesis and maintenance of temporal lobe epilepsy, but the underlying cell and molecular mechanisms are not fully understood. The P2X7 receptor is an ionotropic receptor predominantly expressed on the surface of microglia, although neuronal expression has also been reported. The receptor is activated by the release of ATP from intracellular sources that occurs during neurodegeneration, leading to microglial activation and inflammasome-mediated interleukin 1÷ release that contributes to neuroinflammation. Using a reporter mouse in which green fluorescent protein is induced in response to the transcription of P2rx7, we show that expression of the receptor is selectively increased in CA1 pyramidal and dentate granule neurons, as well as in microglia in mice that developed epilepsy after intra-amygdala kainic acid-induced status epilepticus. P2X7 receptor levels were increased in hippocampal subfields in the mice and in resected hippocampus from patients with pharmacoresistant temporal lobe epilepsy. Cells transcribing P2rx7 in hippocampal slices from epileptic mice displayed enhanced agonist-evoked P2X7 receptor currents, and synaptosomes from these animals showed increased P2X7 receptor levels and altered calcium responses. A 5 d treatment of epileptic mice with systemic injections of the centrally available, potent, and specific P2X7 receptor antagonist JNJ-47965567 (30 mg/kg) significantly reduced spontaneous seizures during continuous video-EEG monitor-ing that persisted beyond the time of drug presence in the brain. Hippocampal sections from JNJ-47965567-treated animals obtained >5d after treatment ceased displayed strongly reduced microgliosis and astrogliosis. The present study suggests that targeting the P2X7 receptor has anticonvulsant and possibly disease-modifying effects in experimental epilepsy.
Docta Complutense
Publication Artículo científico (JournalArticle)

microRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus

  • Jimenez-Mateos, Eva M.
  • Arribas Blázquez, Marina
  • Sanz-Rodriguez, Amaya
  • Concannon, Caoimhin
  • Olivos Ore, Luis Alcides
  • Reschke, Cristina R.
  • Mooney, Claire M.
  • Mooney, Catherine
  • Lugara, Eleonora
  • Morgan, James
  • Langa, Elena
  • Jimenez-Pacheco, Alba
  • Silva, Luiz Fernando Almeida
  • Mesuret, Guillaume
  • Boison, Detlev
  • Miras Portugal, María Teresa
  • Letavic, Michael
  • Rodríguez Artalejo, Antonio
  • Bhattacharya, Anindya
  • Díaz Hernández, Miguel
  • Henshall, David C.
  • Engel, Tobias
The ATP-gated ionotropic P2X7 receptor (P2X7R) modulates glial activation, cytokine production and neurotransmitter release following brain injury. Levels of the P2X7R are increased in experimental and human epilepsy but the mechanisms controlling P2X7R expression remain poorly understood. Here we investigated P2X7R responses after focal-onset status epilepticus in mice, comparing changes in the damaged, ipsilateral hippocampus to the spared, contralateral hippocampus. P2X7Rgated inward currents were suppressed in the contralateral hippocampus and P2rx7 mRNA was selectively uploaded into the RNA-induced silencing complex (RISC), suggesting microRNA targeting. Analysis of RISC-loaded microRNAs using a high-throughput platform, as well as functional assays, suggested the P2X7R is a target of microRNA-22. Inhibition of microRNA-22 increased P2X7R expression and cytokine levels in the contralateral hippocampus after status epilepticus and resulted in more frequent spontaneous seizures in mice. The major pro-inflammatory and hyperexcitability effects of microRNA-22 silencing were prevented in P2rx7-/- mice or by treatment with a specific P2X7R antagonist. Finally, in vivo injection of microRNA-22 mimics transiently suppressed spontaneous seizures in mice. The present study supports a role for post-transcriptional regulation of the P2X7R and suggests therapeutic targeting of microRNA-22 may prevent inflammation and development of a secondary epileptogenic focus in the brain.